Insider · CIK 0001894052
Couling John D
Reports to the SEC for 1 company · SAN FRANCISCO, CA
Transactions
50
Companies
1
Filings
7
CIK
0001894052
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-01 | DLBDolby Laboratories, Inc.S Sale | −$401K |
| 2026-10-01 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-10-01 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-10-01 | DLBDolby Laboratories, Inc.S Sale | −$49.6K |
| 2026-09-15 | DLBDolby Laboratories, Inc.A Award | — |
| 2026-09-01 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-09-01 | DLBDolby Laboratories, Inc.S Sale | −$468K |
| 2026-09-01 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-08-03 | DLBDolby Laboratories, Inc.S Sale | −$46.2K |
| 2026-08-03 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-08-03 | DLBDolby Laboratories, Inc.S Sale | −$414K |
| 2026-08-03 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-01 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-07-01 | DLBDolby Laboratories, Inc.S Sale | −$408K |
| 2026-07-01 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-06-01 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-06-01 | DLBDolby Laboratories, Inc.S Sale | −$398K |
| 2026-06-01 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-06-01 | DLBDolby Laboratories, Inc.S Sale | −$28.5K |
| 2026-05-05 | DLBDolby Laboratories, Inc.S Sale | −$43.1K |
| 2026-05-05 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$349K |
| 2026-05-05 | DLBDolby Laboratories, Inc.S Sale | −$398K |
| 2026-05-05 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-05-04 | DLBDolby Laboratories, Inc.S Sale | −$274K |
| 2026-02-02 | DLBDolby Laboratories, Inc.S Sale | −$433K |
| 2025-12-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$174K |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2025-12-15 | DLBDolby Laboratories, Inc.A Award | — |
| 2025-12-15 | DLBDolby Laboratories, Inc.F Tax Payment | −$554K |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion | — |
| 2025-12-15 | DLBDolby Laboratories, Inc.M Exercise/Conversion | — |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2025-12-11 | DLBDolby Laboratories, Inc.S Sale | −$500K |
| 2025-11-20 | DLBDolby Laboratories, Inc.S Sale | −$408K |
| 2025-05-05 | DLBDolby Laboratories, Inc.S Sale | −$50.7K |
| 2024-12-16 | DLBDolby Laboratories, Inc.A Award | — |
| 2024-12-16 | DLBDolby Laboratories, Inc.M Exercise/Conversion | — |
| 2024-12-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$927K |
| 2024-12-16 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2024-12-16 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2024-12-16 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion | — |
| 2024-11-25 | DLBDolby Laboratories, Inc.S Sale | −$564K |
| 2024-11-25 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$452K |
| 2024-11-25 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-11-22 | DLBDolby Laboratories, Inc.S Sale | −$3.84M |
| 2024-11-22 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$517K |
| 2024-11-22 | DLBDolby Laboratories, Inc.M Exercise/Conversion | +$1.33M |
| 2024-11-22 | DLBDolby Laboratories, Inc.S Sale | −$162K |
| 2024-11-22 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-11-22 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
Recent filings
- 4Couling John D0001193125-26-414725SEC(opens sec.gov)
- 4Couling John D0001193125-26-394493SEC(opens sec.gov)
- 4Couling John D0001193125-26-382329SEC(opens sec.gov)
- 4Couling John D0001193125-26-335473SEC(opens sec.gov)
- 4Couling John D0001193125-26-296456SEC(opens sec.gov)
- 4Couling John D0001193125-26-255624SEC(opens sec.gov)
- 4Couling John D0001193125-26-209338SEC(opens sec.gov)
Companies
Address
C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET
SAN FRANCISCO, CA, 94103